It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The tumor microenvironment (TME) is composed of a heterogeneous biological ecosystem of cellular and non-cellular elements including transformed tumor cells, endothelial cells, immune cells, activated fibroblasts or myofibroblasts, stem and progenitor cells, as well as the cytokines and matrix that they produce. The constituents of the TME stroma are multiple and varied, however cancer associated fibroblasts (CAF) and their contribution to the TME are important in tumor progression. CAF are hypothesized to arise from multiple progenitor cell types, including mesenchymal stem cells. Currently, isolation of TME stroma from patients is complicated by issues such as limited availability of biopsy material and cell stress incurred during lengthy adaptation to atmospheric oxygen (20% O2) in cell culture, limiting pre-clinical studies of patient tumor stromal interactions. Here we describe a microenvironment mimetic in vitro cell culturing system that incorporates elements of the in vivo lung environment, including lung fibroblast derived extracellular matrix and physiological hypoxia (5% O2). Using this system, we easily isolated and rapidly expanded stromal progenitors from patient lung tumor resections without complex sorting methods or growth supplements. These progenitor populations retained expression of pluripotency markers, secreted factors associated with cancer progression, and enhanced tumor cell growth and metastasis. An understanding of the biology of these progenitor cell populations in a TME-like environment may advance our ability to target these cells and limit their effects on promoting cancer metastasis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of Louisville, Department of Pharmacology & Toxicology, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622)
2 University of Louisville, Department of Biochemistry & Molecular Genetics, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622); University of Louisville, Cardiovascular Innovation Institute, Louisville, USA (GRID:grid.470916.d)
3 University of Louisville, James Graham Brown Cancer Center, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622)
4 University of Louisville, Cardiovascular Innovation Institute, Louisville, USA (GRID:grid.470916.d); University of Louisville, Department of Physiology, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622)
5 University of Louisville, Department of Pharmacology & Toxicology, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622); University of Louisville, James Graham Brown Cancer Center, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622)
6 University of Louisville, Department of Pharmacology & Toxicology, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622); University of Louisville, James Graham Brown Cancer Center, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622); University of Louisville, Department of Medicine, Louisville, USA (GRID:grid.266623.5) (ISNI:0000 0001 2113 1622)